🔴 Optimi Health is trading 6.67% down in pre-market with no clear company-specific negative announcement

Optimi Health is trading 6.67% down in pre-market at $4.20, with no clear company-specific negative announcement explaining the pre-market decline.

• It closed at $4.50 on September 10, 2026.
• Optimi announced a Health Canada-authorized Phase 2 depression trial on September 10; management’s H.C. Wainwright presentation became available September 11. Neither is an obvious bearish catalyst.
• Broader indexes were rising, so market-wide sentiment does not clearly explain the move.